Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/antib14040105
PubMed Identifier: 41440494
Publication URI: http://europepmc.org/abstract/MED/41440494
Type: Journal Article/Review
Volume: 14
Parent Publication: Antibodies (Basel, Switzerland)
Issue: 4
ISSN: 2073-4468